These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28133204)

  • 1. [Salvage Surgery after CRT for Advanced Esophageal Cancer Resulting in a Pathological Complete Response and More Than Five Years' Survival].
    Kaida S; Murata S; Yamaguchi T; Ohtake R; Takebayashi K; Yamamoto H; Ueki T; Miyake T; Iida H; Akabori H; Sonoda H; Mori T; Shimizu T; Naka S; Tani M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2007-2009. PubMed ID: 28133204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced esophageal cancer revealed a pathological complete response and survived more than 8 years, treated by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
    Kubo H; Nakasuga C; Tada K; Miyahara M; Hasegawa H; Kondo S; Yamashita Y
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1209-11. PubMed ID: 24047781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Salvage Chemoradiotherapy for Regional Recurrence after Curative Esophagectomy].
    Yamamoto M; Okuno T; Imanishi T; Kanaji S; Yamashita K; Kanemitsu K; Sumi Y; Nakamura T; Suzuki S; Kakeji Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1457-9. PubMed ID: 26805062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Three-Year Survival after Lymphadenectomy for Residual Lymph Node Metastasis of Esophageal Cancer with Invasion into the Trachea and Carotid Artery after Chemoradiotherapy - A Case Report].
    Odagiri K; Yamazaki M; Tanaka K; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):2006-2008. PubMed ID: 29394849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
    Yamashita H; Haga A; Takenaka R; Kiritoshi T; Okuma K; Ohtomo K; Nakagawa K
    Radiat Oncol; 2016 Jan; 11():4. PubMed ID: 26781439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced esophageal cancer invaded to the trachea with PCR after preoperative chemoradiotherapy, which relapsed at the time of three years and seven months after resection].
    Kawasaki H; Wajima N; Miyamoto K; Maruyama A; Takahashi K; Kubo N; Hakamada K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2388-90. PubMed ID: 22202391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathological complete response in 2 patients with cT4 esophageal cancer treated with neoadjuvant chemoradiation therapy].
    Takagawa R; Mogaki M; Endo C; Kubo H; Nakayama G; Goto A; Homma Y; Minami Y; Watanabe J; Morita T; Masui H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2149-51. PubMed ID: 24394042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of primary esophageal carcinoma treated with 5-fluorouracil plus cisplatin and curatively resected after complete response].
    Iwasaki K; Ogata T; Fujikawa H; Shirai J; Cho H; Yoshikawa T; Ohta Y; Tachibana S; Oosaka Y; Tsuchida A
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2146-8. PubMed ID: 24394041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of advanced esophageal cancer patient surviving more than 7 years treated with chemoradiotherapy].
    Kubo N; Kawasaki H; Takahashi K; Maruyama M; Miyamoto K; Wajima N; Hakamada K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2385-7. PubMed ID: 22202390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer.
    Morita M; Toh Y; Saeki H; Sugiyama M; Ohgaki K; Maehara S; Minami K; Ikeda Y; Sakaguchi Y; Okamura T; Uehara S; Maehara Y
    Anticancer Res; 2012 Aug; 32(8):3275-82. PubMed ID: 22843902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Advanced Esophageal Cancer Successfully Treated with DCF Chemotherapy Followed by Conversion Surgery].
    Okada K; Takeoka T; Miki H; Kobayashi K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1623-1625. PubMed ID: 29394722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
    Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer.
    Kobayashi R; Yamashita H; Okuma K; Shiraishi K; Ohtomo K; Nakagawa K
    Dis Esophagus; 2014 Jan; 27(1):72-8. PubMed ID: 23551708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
    Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
    J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas.
    Toh Y; Ohga T; Itoh S; Kabashima A; Yamamoto K; Adachi E; Sakaguchi Y; Okamura T; Hirata H
    Anticancer Res; 2006; 26(3B):2487-91. PubMed ID: 16821637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of reversible encephalopathy syndrome caused by hyponatremia during neoadjuvant 5-FU+CDDP therapy for esophageal cancer].
    Kobayashi Y; Nozaki I; Hato S; Kobatake T; Ohta K; Kubo Y; Tanada M; Kurita A
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):379-81. PubMed ID: 23507603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Correlation Between Clinical Complete Response and Pathological Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer?
    Liu SL; Xi M; Yang H; Yang YD; Wu YJ; Zhao L; Zhang P; Luo LL; Liu MZ
    Ann Surg Oncol; 2016 Jan; 23(1):273-81. PubMed ID: 26215200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.